CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | TYNDALL JOSEPH A. Director | Sale | −2,525 | $11.63 | $29K | 22,557 |
| 2025-05-12 | Hartley Lindsey Marie CFO | Grant or award · Restricted Stock Units | +26,000 | 26,000 | ||
| 2025-03-25 | Kemp Jens Chief Marketing Officer | Grant or award · Restricted Stock Units | +38,000 | 38,000 | ||
| 2025-03-25 | DeVinney Erick Wayne Chief Innovation Officer | Grant or award · Restricted Stock Units | +38,000 | 38,000 | ||
| 2025-03-25 | DALE MICHAEL D Chief Executive Officer | Grant or award · Restricted Stock Units | +176,300 | 176,300 | ||
| 2025-03-25 | Began Marc A EVP & General Counsel | Grant or award · Restricted Stock Units | +55,000 | 55,000 | ||
| 2025-03-19 | DeVinney Erick Wayne Chief Innovation Officer | Sale | −15,111 | $17.50 | $264K | 217,762 |
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +2,950 | 203,361 | ||
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +6,362 | 209,723 | ||
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +23,150 | 232,873 | ||
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −2,950 | 0 | ||
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −6,362 | 6,363 | ||
| 2025-03-16 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise · Restricted Stock Units | −23,150 | 23,150 | ||
| 2025-03-04 | Kemp Jens Chief Marketing Officer | Shares withheld for taxes | −4,003 | $18.36 | $73K | 27,683 |
| 2025-03-04 | Began Marc A EVP & General Counsel | Shares withheld for taxes | −5,901 | $18.36 | $108K | 18,285 |
| 2025-03-04 | DeVinney Erick Wayne Chief Innovation Officer | Shares withheld for taxes | −8,296 | $18.35 | $152K | 201,005 |
| 2025-03-03 | Wendell Amy McBride Director | Sale | −5,000 | $20.02 | $100K | 97,899 |
| 2025-03-01 | Began Marc A EVP & General Counsel | Option exercise | +22,500 | 24,186 | ||
| 2025-03-01 | Began Marc A EVP & General Counsel | Option exercise · Restricted Stock Units | −22,500 | 22,500 | ||
| 2025-02-28 | DeVinney Erick Wayne Chief Innovation Officer | Option exercise | +24,799 | 209,301 |
Page 10 of 61 · 1,220 trades